US Broker Ratings

AptarGroup, Inc. (ATR) Stock Analysis: Healthcare Innovator with 23.63% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, is drawing investor attention with its significant growth potential. The company, headquartered in Crystal Lake, Illinois, is renowned for..

Avidity Biosciences, Inc. (RNA) Investor Outlook: Exploring a 44% Upside Potential in RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA), a pioneering force in the biotechnology sector, is capturing investor attention due to its innovative approach to RNA therapeutics. With a market cap of $5.98..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Closer Look at Healthcare’s Prominent Player with a 2.1% Dividend Yield

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a significant player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $16.04 billion, the..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Robust 21% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) is making waves in the healthcare sector, specifically within the niche of drug manufacturers specializing in both specialty and generic products. With a market capitalization..

Glaukos Corporation (GKOS) Stock Analysis: Evaluating Growth Potential and Market Position

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, is garnering attention for its innovative approaches to treating ocular diseases. Headquartered in Aliso Viejo,..

Guardant Health, Inc. (GH) Stock Analysis: Navigating a 30.90% Revenue Surge Amid a Challenging Valuation Landscape

Guardant Health, Inc. (NASDAQ: GH), a key player in the healthcare sector, is making waves in the diagnostics and research industry with its innovative precision oncology solutions. Headquartered in Palo..

TransMedics Group, Inc. (TMDX) Stock Analysis: Potential Upside Amidst Rapid Revenue Growth

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly within the medical devices industry, with its innovative approach to organ transplant therapy. As a commercial-stage medical..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 9.29% Upside Amid Strong Buy Ratings

Investors looking for opportunities in the healthcare sector may want to focus their attention on RadNet, Inc. (RDNT), a leader in the diagnostics and research industry. With a market capitalization..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Unpacking a 26% Revenue Growth with High Upside Potential

Investors looking at iRhythm Technologies, Inc. (NASDAQ: IRTC) are witnessing an intriguing opportunity in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $5.16 billion,..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating Growth with a 4.11% Upside Potential

The Ensign Group, Inc. (NASDAQ: ENSG) is making waves in the healthcare sector, particularly in the medical care facilities industry. With a current market capitalization of $9.59 billion, this U.S.-based..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Potential Upside Nears 100% with Robust Growth

Telix Pharmaceuticals Limited (ASX: TLX), an Australian-based biotechnology company, is making waves in the healthcare sector with its innovative approach to therapeutic and diagnostic radiopharmaceuticals. As a commercial-stage biopharmaceutical organization,..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Look at Its Growth Potential and Analyst Consensus

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector, specializes in medical devices with a robust focus on orthopedic reconstructive products. With a market capitalization of..

STERIS plc (STE) Stock Analysis: Exploring a Promising 10.01% Upside for Investors

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, is making waves with its robust portfolio of infection prevention products and services. Headquartered in Mentor, Ohio, and boasting..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A Look at the Healthcare Giant’s 6.8% Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands out as a formidable player in the healthcare sector, specifically within the Diagnostics & Research industry. With a commanding market cap of $52.07 billion,..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 64% Potential Upside in the Medical Device Industry

Investors seeking opportunities in the healthcare sector might want to keep a close watch on Inspire Medical Systems, Inc. (NASDAQ: INSP). This medical technology company, with a market capitalization of..

Qiagen N.V. (QGEN) Stock Analysis: Unlocking Potential with 6.16% Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector specializing in diagnostics and research, is drawing attention from investors with a potential upside of 6.16%, based on its..

CVS Health Corporation (CVS): Investor Outlook Highlights a Promising 17.82% Upside Potential

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to a diversified healthcare model. With a market capitalization of..

Vaxcyte, Inc. (PCVX) Stock Analysis: A 251% Potential Upside Catches Investor Attention

For investors seeking promising opportunities in the healthcare sector, Vaxcyte, Inc. (NASDAQ: PCVX) offers a compelling case with a substantial potential upside. This biotechnology company, based in San Carlos, California,..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a -28.75% Potential Downside with Strategic Insights

Oscar Health, Inc. (NYSE: OSCR) sits at a pivotal juncture in the healthcare sector, offering a unique blend of technology-driven insurance products. As a significant player in the healthcare plans..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 39.40% Potential Upside

For investors with a keen eye on the healthcare sector, Bruker Corporation (NASDAQ: BRKR) presents a compelling case, particularly with its notable 39.40% potential upside. Despite facing some recent challenges,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds